Encinitas, CA, United States of America

Harry Jay Linton

This inventor holds 1 USPTO granted patent. Top assignee: Beckman Coulter, Inc.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Harry Jay Linton

Introduction

Harry Jay Linton is a notable inventor based in Encinitas, CA. He has made significant contributions to the field of immunology, particularly through his work on monoclonal antibodies. His innovative approach has led to advancements in the detection of specific protein complexes, which can have important implications in medical diagnostics.

Latest Patents

Linton holds a patent for "Monoclonal antibodies specific for the PSA-ACT complex." This invention involves the development of monoclonal antibodies that specifically bind to the PSA-ACT complex without significant cross-reactivity with PSA, ACT, or CG-ACT. The antibodies were generated using a unique immunogen that comprises a PSA-ACT complex bound to monoclonal antibodies against PSA and ACT. It is theorized that these antibodies block immunodominant sites on the PSA-ACT complex, allowing for specific detection in immunoassays.

Career Highlights

Linton is associated with Beckman Coulter, Inc., where he continues to contribute to innovative research and development in the field of diagnostics. His work has been instrumental in enhancing the accuracy of immunoassays, which are critical for various medical applications.

Collaborations

Some of Linton's notable coworkers include Tang Jang Wang and Kristine Kuus-Reichel. Their collaborative efforts have further advanced the research and development of monoclonal antibodies and their applications in medical diagnostics.

Conclusion

Harry Jay Linton's contributions to the field of immunology through his innovative patents and collaborations highlight the importance of research in developing effective diagnostic tools. His work continues to influence the medical community and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…